What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
The scientist’s investigation covers issues in Surgery, Radiation therapy, Glioma, Brachytherapy and Pathology.
The concepts of his Surgery study are interwoven with issues in Anaplastic astrocytoma, Internal medicine and Oncology.
Particularly relevant to Radiosurgery is his body of work in Radiation therapy.
His Glioma research integrates issues from Blood flow, Blood oxygenation level dependent and Premovement neuronal activity.
His Brachytherapy study incorporates themes from Survival rate, Survival analysis and Craniotomy.
The study incorporates disciplines such as Animal model, Central nervous system and In vivo in addition to Pathology.
His most cited work include:
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO (444 citations)
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality (422 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Radiation therapy, Nuclear medicine, Radiology and Glioma.
His Surgery research focuses on Internal medicine and how it connects with Procarbazine.
His Radiation therapy study combines topics in areas such as Anaplastic astrocytoma, Chemotherapy and Oncology.
His research in Oncology intersects with topics in Bevacizumab and Temozolomide.
His study in Nuclear medicine is interdisciplinary in nature, drawing from both Radiation treatment planning, Magnetic resonance imaging, Irradiation and Meningioma.
His Glioma research is multidisciplinary, incorporating perspectives in Brain tumor and Pathology.
He most often published in these fields:
- Surgery (39.12%)
- Radiation therapy (38.17%)
- Nuclear medicine (22.08%)
What were the highlights of his more recent work (between 2010-2020)?
- Surgery (39.12%)
- Radiology (16.72%)
- Radiation therapy (38.17%)
In recent papers he was focusing on the following fields of study:
Philip H. Gutin spends much of his time researching Surgery, Radiology, Radiation therapy, Glioma and Internal medicine.
Philip H. Gutin has included themes like Malignancy and Cohort in his Surgery study.
The Radiology study combines topics in areas such as Cancer and Nuclear medicine.
His Radiation therapy research is multidisciplinary, incorporating elements of In vivo magnetic resonance spectroscopy, Progression-free survival, High-Grade Glioma and Medical imaging.
His work carried out in the field of Glioma brings together such families of science as Neurosurgery, Preoperative care and Surgical planning.
His Internal medicine study frequently draws connections to adjacent fields such as Oncology.
Between 2010 and 2020, his most popular works were:
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO (444 citations)
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality (422 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Philip H. Gutin focuses on Surgery, Glioma, Cancer research, Radiation therapy and Magnetic resonance imaging.
His biological study spans a wide range of topics, including Internal medicine, Clinical trial, Radiology and Histopathology.
His work on Improved survival, Multiple cancer, Immunotherapy and Immune checkpoint inhibitors as part of general Internal medicine research is frequently linked to Text mining, thereby connecting diverse disciplines of science.
His Glioma research includes themes of Neurosurgery, Pathology, Metabolite and Intraoperative MRI.
His Radiation therapy research includes elements of Time to recurrence, Resection and Medical record.
His Imaging biomarker study, which is part of a larger body of work in Magnetic resonance imaging, is frequently linked to Mitotic index, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
